Effects and interactions of opioids on plasma exudation induced by cigarette smoke in guinea pig bronchi

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 276, Issue 3 20-3, 1999, Pages

  Lei, Yu Hong ^a,b   Rogers, Duncan F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

Opioid receptor; Sensory nerve; Vascular permeability

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANTIHISTAMINIC AGENT; CIGARETTE SMOKE; CROMOGLYCATE DISODIUM; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE DERIVATIVE; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRONCHOSPASM; BRONCHUS; BRONCHUS HYPERREACTIVITY; BRONCHUS SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EFFERENT NERVE; GUINEA PIG; HISTAMINE RELEASE; INFLAMMATION; INHALATION; MALE; MAST CELL; MUCUS SECRETION; NONHUMAN; PLASMA; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SMOKING;

EID: 0032901324     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.276.3.l391     Document Type: Article

References (36)

1. Barnes, P. J., M. G. Belvisi, and D. F. Rogers. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol. Sci. 11: 185-189, 1991.
2. Belvisi, M. G., K. F. Chung, D. M. Jackson, and P. J. Barnes. Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo. Br. J. Pharmacol. 95: 413-418, 1988.
3. Belvisi, M. G., C. D. Stretton, and P. J. Barnes. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids. Br. J. Pharmacol. 100: 131-137, 1990.
4. Casale, T. B., S. Bowman, and M. Kaliner. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and non-opiate receptor participation. J. Allergy Clin. Immunol. 73: 775-781, 1984.
5. Cox, J. S. G. Disodium cromoglycate (cromolyn sodium) in bronchial asthma. In: Bronchial Asthma-Mechanisms and Therapeutics, edited by E. B. Weiss and M. S. Segal. Boston, MA: Little, Brown, 1976, p. 805-837.
6. 1 antagonist, CP-96,345. Eur. J. Pharmacol. 203: 157-158, 1991.
7. Dhawan, B. N., F. Cesselin, R. Raghubir, T. Reisine, P. B. Bradley, P. S. Portoghese, and M. Hamon. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 48: 567-592, 1996.
8. 1 receptors. Eur. J. Pharmacol. 209: 277-279, 1991.
9. Ennis, M., C. Schneider, E. Nehring, and W. Lorenze. Histamine release induced by opioid analgesics: a comparative study using porcine mast cells. Agents Actions 33: 20-22, 1991.
10. Evans, T. W., D. F. Rogers, B. Aursudkij, K. F. Chung, and P. J. Barnes. Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig. Clin. Sci. (Colch.) 76: 479-485, 1989.
11. Feldberg, W., and W. D. H. Paton. Release of histamine by morphine alkaloids (Abstract). J. Physiol. (Lond.) 111: 19p, 1950.
12. Gillan, M. G. C., and H. W. Kosterlitz. Spectrum of the μ-, δ- and κ-binding sites in homogenates of rat brain. Br. J. Pharmacol. 77: 461-469, 1982.
13. Grosman, N. Histamine release from isolated rat mast cells: effect of morphine and related drugs and their interaction with compound 48/80. Agents Actions 11: 196-203, 1981.
14. Heyman, J. S., Q. Jiang, R. B. Rothman, H. I. Mosberg, and F. Porreca. Modulation of μ-mediated antinociception by δ agonists: characterisation with antagonists. Eur. J. Pharmacol. 169: 43-52, 1989.
15. Hirayama, Y., Y.-H. Lei, P. J. Barnes, and D. F. Rogers. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo. Br. J. Pharmacol. 108: 844-851, 1993.
16. Itzhak, Y. Multiple opioid binding sites. In: The Opioid Receptor, edited by G. W. Pasternak. Totowa, NJ: Humana, 1988, p. 100-105.
17. Kamei, J., H. Tanihara, and Y. Kasuya. Modulation of μ-mediated antitussive activity in rats by a δ agonist. Eur. J. Pharmacol. 203: 153-156, 1991.
18. Kamei, J., H. Tanihara, and K. Yutaka. Modulation of κ-mediated antitussive activity in rat by a δ agonist. Res. Commun. Chem. Pathol. Pharmacol. 76: 375-378, 1992.
19. Karlsson, J. A., A. S. Lanner, and C. G. Persson. Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J. Pharmacol. Exp. Ther. 252: 863-868, 1990.
20. Kuo, H.-P., J. A. L. Rhode, P. J. Barnes, and D. F. Rogers. Differential inhibitory effects of opioids on cigarette smoke, capsaicin and electrically-induced goblet cell secretion in guinea-pig trachea. Br. J. Pharmacol. 105: 361-366, 1992.
21. Laduron, P. M. Axonal transport of opiate receptors in capsaicin-sensitive neurones. Brain Res. 294: 157-160, 1984.
22. Lahti, R. A., P. F. Von Voigtlander, and C. Barsuhn. Properties of a selective κ agonist, U-50,488H. Life Sci. 31: 2257-2260, 1982.
23. 1 receptor antagonist. Br. J. Pharmacol. 105: 261-262, 1992.
24. Lei, Y.-H., P. J. Barnes, and D. F. Rogers. Mechanisms and modulation of airway plasma exudation after direct inhalation of cigarette smoke. Am. J. Respir. Crit. Care Med. 151: 1752-1762, 1995.
25. Lewis, T. Blood Vessels of Human Skin and Their Responses. London: Shaw & Sons, 1927.
26. Lundberg, J. M., C. R. Martling, A. Saria, K. Folkers, and S. Rosell. Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release. Neuroscience 10: 1361-1368, 1983.
27. Maggi, C. A., and A. Meli. The sensory-efferent function of capsaicin-sensitive sensory neurones. Gen. Pharmacol. 19: 1-43, 1988.
28. Mosberg, H. I., R. Hurst, V. J. Hruby, K. Gee, H. I. Yamamura, J. J. Galligan, and T. F. Burks. Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors. Proc. Natl. Acad. Sci. USA 80: 5871-5874, 1983.
29. Nasmyth, P.A., and H. C. Stewart. The release of histamine by opium alkaloids (Abstract). J. Physiol. (Lond.) 111: 20p, 1950.
30. Neiber, K., C. R. Baumgarten, R. Rathsack, J. Furket, P. Oehme, and G. Kunkel. Substance P and Β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90: 646-652, 1992.
31. Pan, Z. Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol. Sci. 19: 94-98, 1998.
32. Ca channels in ferret trachea in vitro. Br. J. Pharmacol. 123: 1631-1638, 1998.
33. Ray, N. J., A. J. Jones, and P. Keen. Morphine, but not sodium cromoglygate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br. J. Pharmacol. 102: 797-800, 1991.
34. Rogers, D. F., and P. J. Barnes. Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet 1: 930-932, 1989.
35. Rogers, D. F., P. Boschetto, and P. J. Barnes. Plasma exudation: correlation between Evans blue dye and radiolabelled albumin in guinea pig airways in vivo. J. Pharmacol. Methods 21: 309-315, 1989.
36. 1) receptor. Science 251: 435-437, 1991.